Literature DB >> 11168756

The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma.

I B Bayer-Garner1, B R Smoller.   

Abstract

BACKGROUND: Syndecan-1 and E-cadherin are cell adhesion molecules which are expressed primarily on the surface of adult epithelial cells. They appear to be co-regulated and may act in concert to stabilize the epithelium. Loss of expression of both E-cadherin and syndecan-1 is seen in malignant transformation and invasion.
METHODS: Thirteen cutaneous biopsies of acantholytic squamous cell carcinoma (SCC) were examined for coexpression of E-cadherin and syndecan-1.
RESULTS: Interestingly, immunoreactivity for E-cadherin was increased in the in situ component while immunoreactivity for syndecan-1 was similar to that seen in normal skin. Conversely, in invasive SCC the expression of these two adhesion molecules was very similar. Both diminished with decreasing cell differentiation, as well as in the acantholytic areas where both molecules exhibited increasing cytosolic staining rather than cell membrane staining.
CONCLUSIONS: Our results suggest that it is likely E-cadherin and syndecan-1 act in concert to stabilize the epithelium and that the loss or decreased expression of both of these adhesion molecules is associated with malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168756     DOI: 10.1034/j.1600-0560.2001.280204.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  11 in total

1.  Desmosomal defects in acantholytic squamous cell carcinomas.

Authors:  Charlene O'Shea; James E Fitzpatrick; Peter J Koch
Journal:  J Cutan Pathol       Date:  2014-11-04       Impact factor: 1.587

2.  Immunohistochemical and cytogenetic characterization of acantholytic squamous cell carcinoma of the breast.

Authors:  Sebastian Aulmann; Philipp A Schnabel; Birgit Helmchen; Hendrik Dienemann; Peter Drings; Herwart F Otto; Hans Peter Sinn
Journal:  Virchows Arch       Date:  2005-01-25       Impact factor: 4.064

Review 3.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

4.  Pseudovascular adenoid squamous-cell carcinoma of the oral cavity--a report of two cases.

Authors:  N Zidar; N Gale; A Zupevc; D Dovsak
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

Review 5.  New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.

Authors:  Innoc Han; Haein Park; Eok-Soo Oh
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

6.  Primary acantholytic squamous cell carcinoma of the cecum: a case report.

Authors:  Zoran Jukić; Iva Ledinsky; Monika Ulamec; Mario Ledinsky; Božo Krušlin; Davor Tomas
Journal:  Diagn Pathol       Date:  2011-01-11       Impact factor: 2.644

Review 7.  Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication.

Authors:  Tünde Szatmári; Rita Ötvös; Anders Hjerpe; Katalin Dobra
Journal:  Dis Markers       Date:  2015-09-01       Impact factor: 3.434

Review 8.  Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.

Authors:  Mohamed R Akl; Poonam Nagpal; Nehad M Ayoub; Sathyen A Prabhu; Matthew Gliksman; Betty Tai; Ahmet Hatipoglu; Andre Goy; K Stephen Suh
Journal:  Oncotarget       Date:  2015-10-06

9.  The expression of syndecan-1 in psoriatic epidermis.

Authors:  Davor Tomas; Majda Vucić; Mirna Situm; Bozo Kruslin
Journal:  Arch Dermatol Res       Date:  2008-04-02       Impact factor: 3.017

Review 10.  A rare acantholytic variant of squamous cell carcinoma of the maxilla: A case report and literature review.

Authors:  Jo-Eun Kim; Chena Lee; Kyu-Young Oh; Kyung-Hoe Huh
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.